Consolidated Statements of Changes in Equity (Unaudited) - USD ($) $ in Thousands	Total	Total Stockholders’ equity	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit	Operating Partnership Unitholders’ Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2023			21,960,211
Beginning balance at Dec. 31, 2023	$ 301,625	$ 243,562	$ 219	$ 287,268	$ 4,621	$ (48,546)	$ 58,063
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net proceeds from sale of common stock (in shares)			576,087
Net proceeds from sale of common stock	7,867	7,867	$ 6	7,861
Issuance of operating partnership units in connection with acquisition transactions	5,788						5,788
Issuance and amortization of equity-based compensation, net of forfeitures (in shares)			120,941
Issuance and amortization of equity-based compensation, net of forfeitures	2,113	1,148	$ 1	1,147			965
Issuance and amortization under the employee stock purchase plan ("ESPP") (in shares)			5,137
Issuance and amortization under the employee stock purchase plan ("ESPP")	77	77		77
Restricted stock withholdings (in shares)			(27,919)
Restricted stock withholdings	(396)	(396)		(396)
Dividends and distributions	(6,859)	(5,520)				(5,520)	(1,339)
Unrealized gain (loss) on derivative instruments	2,819	2,267			2,267		552
Net income	256	206				206	50
Reallocation of non-controlling interest	0	(1,079)		(1,079)			1,079
Ending balance (in shares) at Mar. 31, 2024			22,634,457
Ending balance at Mar. 31, 2024	313,290	248,132	$ 226	294,878	6,888	(53,860)	65,158
Beginning balance (in shares) at Dec. 31, 2023			21,960,211
Beginning balance at Dec. 31, 2023	301,625	243,562	$ 219	287,268	4,621	(48,546)	58,063
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized gain (loss) on derivative instruments	(2,942)
Net income	2,638
Ending balance (in shares) at Sep. 30, 2024			23,340,391
Ending balance at Sep. 30, 2024	308,966	245,554	$ 233	306,046	2,316	(63,041)	63,412
Beginning balance (in shares) at Mar. 31, 2024			22,634,457
Beginning balance at Mar. 31, 2024	313,290	248,132	$ 226	294,878	6,888	(53,860)	65,158
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net proceeds from sale of common stock (in shares)			57,993
Net proceeds from sale of common stock	685	685	$ 1	684
Shares issued upon redemption of operating partnership units (in shares)			52,778
Shares issued upon redemption of operating partnership units	0	862	$ 1	861			(862)
Issuance and amortization of equity-based compensation, net of forfeitures (in shares)			(316)
Issuance and amortization of equity-based compensation, net of forfeitures	1,433	722		722			711
Issuance and amortization under the employee stock purchase plan ("ESPP")	6	6		6
Dividends and distributions	(6,928)	(5,490)				(5,490)	(1,438)
Unrealized gain (loss) on derivative instruments	14	11			11		3
Net income	1,032	817				817	215
Reallocation of non-controlling interest	0	(265)		(265)			265
Ending balance (in shares) at Jun. 30, 2024			22,744,912
Ending balance at Jun. 30, 2024	309,532	245,480	$ 228	296,886	6,899	(58,533)	64,052
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net proceeds from sale of common stock (in shares)			601,266
Net proceeds from sale of common stock	8,379	8,379	$ 5	8,374
Issuance of operating partnership units in connection with acquisition transactions	1,122						1,122
Issuance and amortization of equity-based compensation, net of forfeitures (in shares)			1,738
Issuance and amortization of equity-based compensation, net of forfeitures	1,456	759		759		0	697
Issuance and amortization under the employee stock purchase plan ("ESPP") (in shares)			8,912
Issuance and amortization under the employee stock purchase plan ("ESPP")	118	118		118
Restricted stock withholdings (in shares)			(12,961)
Restricted stock withholdings	(184)	(184)		(184)
Dividends and distributions	(7,031)	(5,579)				(5,579)	(1,452)
Unrealized gain (loss) on derivative instruments	(5,775)	(4,583)			(4,583)		(1,192)
Net income	1,349	1,071				1,071	278
Reallocation of non-controlling interest	0	93		93			(93)
Ending balance (in shares) at Sep. 30, 2024			23,340,391
Ending balance at Sep. 30, 2024	308,966	245,554	$ 233	306,046	2,316	(63,041)	63,412
Beginning balance (in shares) at Dec. 31, 2024			23,521,693
Beginning balance at Dec. 31, 2024	317,498	251,285	$ 235	310,031	5,230	(64,211)	66,213
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net proceeds from sale of common stock (in shares)			139,626
Net proceeds from sale of common stock	1,820	1,820	$ 1	1,819
Issuance of operating partnership units in connection with acquisition transactions	1,026						1,026
Issuance and amortization of equity-based compensation, net of forfeitures (in shares)			77,623
Issuance and amortization of equity-based compensation, net of forfeitures	2,332	818	$ 1	817			1,514
Issuance and amortization under the employee stock purchase plan ("ESPP") (in shares)			5,527
Issuance and amortization under the employee stock purchase plan ("ESPP")	77	77		77
Restricted stock withholdings (in shares)			(21,092)
Restricted stock withholdings	(277)	(277)		(277)
Dividends and distributions	(7,382)	(5,761)				(5,761)	(1,621)
Unrealized gain (loss) on derivative instruments	(2,844)	(2,229)			(2,229)		(615)
Net income	2,655	2,082				2,082	573
Reallocation of non-controlling interest	0	(2,336)		(2,336)			2,336
Ending balance (in shares) at Mar. 31, 2025			23,723,377
Ending balance at Mar. 31, 2025	314,905	245,479	$ 237	310,131	3,001	(67,890)	69,426
Beginning balance (in shares) at Dec. 31, 2024			23,521,693
Beginning balance at Dec. 31, 2024	317,498	251,285	$ 235	310,031	5,230	(64,211)	66,213
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized gain (loss) on derivative instruments	(5,002)
Net income	12,210
Ending balance (in shares) at Sep. 30, 2025			25,946,621
Ending balance at Sep. 30, 2025	348,477	273,928	$ 259	344,639	1,328	(72,298)	74,549
Beginning balance (in shares) at Mar. 31, 2025			23,723,377
Beginning balance at Mar. 31, 2025	314,905	245,479	$ 237	310,131	3,001	(67,890)	69,426
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net proceeds from sale of common stock (in shares)			529,828
Net proceeds from sale of common stock	7,561	7,561	$ 5	7,556
Issuance of operating partnership units in connection with acquisition transactions	5,005						5,005
Shares issued upon redemption of operating partnership units (in shares)			11,198
Shares issued upon redemption of operating partnership units	0	157		157			(157)
Issuance and amortization of equity-based compensation, net of forfeitures	1,570	700		700			870
Issuance and amortization under the employee stock purchase plan ("ESPP")	19	19		19
Dividends and distributions	(7,553)	(5,822)				(5,822)	(1,731)
Unrealized gain (loss) on derivative instruments	(1,625)	(1,257)			(1,257)		(368)
Net income	4,672	3,614				3,614	1,058
Reallocation of non-controlling interest	0	351		351			(351)
Ending balance (in shares) at Jun. 30, 2025			24,264,403
Ending balance at Jun. 30, 2025	324,554	250,802	$ 242	318,914	1,744	(70,098)	73,752
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net proceeds from sale of common stock (in shares)			1,677,683
Net proceeds from sale of common stock	25,365	25,365	$ 17	25,348
Issuance of operating partnership units in connection with acquisition transactions	715						715
Issuance and amortization of equity-based compensation, net of forfeitures (in shares)			19,679
Shares issued upon redemption of operating partnership units (in shares)			14,320
Shares issued upon redemption of operating partnership units	0	190		190			(190)
Issuance and amortization of equity-based compensation, net of forfeitures	1,111	519		519			592
Issuance and amortization under the employee stock purchase plan ("ESPP") (in shares)			9,894
Issuance and amortization under the employee stock purchase plan ("ESPP")	122	122		122
Restricted stock withholdings (in shares)			0
Restricted stock withholdings	(17)	(17)		(17)
Dividends and distributions	(7,723)	(6,010)				(6,010)	(1,713)
Unrealized gain (loss) on derivative instruments	(533)	(416)			(416)		(117)
Net income	4,883	3,810				3,810	1,073
Reallocation of non-controlling interest	0	(437)		(437)			437
Ending balance (in shares) at Sep. 30, 2025			25,946,621
Ending balance at Sep. 30, 2025	$ 348,477	$ 273,928	$ 259	$ 344,639	$ 1,328	$ (72,298)	$ 74,549